Cargando…
Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India
BACKGROUND: Coronavirus disease 2019 (COVID-19) continues to be a major global public health crisis that exacts significant human and economic costs. Booster vaccination of individuals can improve waning immunity and reduce the impact of community epidemics. METHODS: Using an epidemiological model t...
Autores principales: | Du, Zhanwei, Wang, Lin, Bai, Yuan, Feng, Shuo, Ramachandran, Sabareesh, Lim, Wey Wen, Lau, Eric H.Y., Malani, Anup, Cowling, Benjamin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922587/ https://www.ncbi.nlm.nih.gov/pubmed/36827972 http://dx.doi.org/10.1016/j.medj.2023.02.001 |
Ejemplares similares
-
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India
por: Du, Zhanwei, et al.
Publicado: (2022) -
Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies
por: Feng, Shuo, et al.
Publicado: (2023) -
A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice
por: Silva-Cayetano, Alyssa, et al.
Publicado: (2021) -
Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants
por: Seki, Yohei, et al.
Publicado: (2022) -
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)